Mutations of the p16 gene in gliomas

Loading...
Thumbnail Image

Date

Authors

Kyritsis, A. P.
Zhang, B.
Zhang, W.
Xiao, M.
Takeshima, H.
Bondy, M. L.
Cunningham, J. E.
Levin, V. A.
Bruner, J.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Type of the conference item

Journal type

peer-reviewed

Educational material type

Conference Name

Journal name

Oncogene

Book name

Book series

Book edition

Alternative title / Subtitle

Description

In the present study we investigated the frequency of p16 gene exon 2 mutations in 35 malignant gliomas, using either direct sequencing of the PCR products or cloning into the pCRII vector and sequencing of the cloned PCR products. No mutations were detected during direct sequencing of the PCR products. However, after sequencing of individual clones, we found multiple mutations in 5 tumors involving codons 73(GCC to ACC, Ala to Thr), 76 (GCC to GTC, Ala to Val), 85(GCT to ACT, Ala to Thr), 98(CAC to TAC, His to Tyr), 102 (GCG to GTG, Ala to Val), 106 (GTG to ATG, Val to Met), 107 (CGC to TGC, Arg to Cys), 127 (GCA to GTA, Ala to Val), 128 (CGG to TGG, Arg to Trp) and 136 (GGC to GAC, Gly to Asp). Mutations were found only in glioblastomas and were either C to T or G to A transitions. Each mutation was detected in a small percentage of tumor cells (1.3-22%) using individual colony sequencing and southern hybridization with mutant oligonucleotides, consistent with the heterogenous cell population of glioblastomas. The presence of p16 gene mutations only in glioblastomas suggests that they are late events in glioma development.

Description

Keywords

Adult, Base Sequence, Brain Neoplasms/*genetics, Carrier Proteins/*genetics, Cyclin-Dependent Kinase Inhibitor p16, Glioma/*genetics, Humans, Molecular Sequence Data, *Mutation, Polymerase Chain Reaction

Subject classification

Citation

Link

http://www.ncbi.nlm.nih.gov/pubmed/8552400

Language

en

Publishing department/division

Advisor name

Examining committee

General Description / Additional Comments

Institution and School/Department of submitter

Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής

Table of contents

Sponsor

Bibliographic citation

Name(s) of contributor(s)

Number of Pages

Course details

Endorsement

Review

Supplemented By

Referenced By